In light of the growing body of evidence supporting the Hippo-YAP pathway’s involvement in skin disorders, it is imperative to foster interdisciplinary collaboration among researchers, clinicians, and pharmaceutical developers. The gene discussed is YAP1; the disease is skin disorder.